Lead party: ADQ (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Amoun Pharmaceutical Company S.A.E. (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Egypt
Transaction type: Merger/Acquisition(M&A), Exit · Asset class: Corporate Transactions · Deal amount: US$740m · Equity stake: 1% · Implied EV: US$740m
Lead investor/buyer: ADQ · Investors/buyers: ADQ · Sellers: Bausch Health Companies Inc., Undisclosed Investors
Legal advisers: not identified in the source record.
Source: announced 31 March 2021. Original announcement: adq.ae.


